Cardinal Health (Australia)

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

Background: Biliary tract cancers (BTCs) are aggressive malignancies with limited treatment options. The addition of durvalumab or pembrolizumab to cisplatin–gemcitabine improves overall survival (OS), but validated biomarkers of benefit remain limited. Immune-mediated adverse ev...

The Cardinal Decision Evidence Assessment, Version 1.1

Regulated firms may be unable to rebuild the AI-assisted decisions they have already made, and few know whether they can, because the question is rarely asked until the decision is being contested. This document sets out an applied test for whether they can. Six tests examine whe...

The Cardinal Decision Evidence Assessment, Version 1.0

Regulated firms increasingly cannot rebuild the AI-assisted decisions they have already made. This document sets out an applied test for whether they can. Six tests, evaluated in dependency order, examine whether the inputs, system state and human judgement behind a specific past...